Literature DB >> 34643120

Morphometric evaluation of traumatic axonal injury and the correlation with post-traumatic cerebral atrophy and functional outcome.

Cedric Bohyn1, Thijs Vande Vyvere2, Frederik De Keyzer3, Diana M Sima2, Philippe Demaerel1.   

Abstract

INTRODUCTION: Imaging plays a crucial role in the diagnosis, prognosis and follow-up of traumatic brain injury. Whereas computed tomography plays a pivotal role in the acute setting, magnetic resonance imaging is best suited to detect the true extent of traumatic brain injury, and more specifically diffuse axonal injury. Post-traumatic brain atrophy is a well-known complication of traumatic brain injury.
PURPOSE: This study investigated the correlation between diffuse axonal injury detected with fluid-attenuated inversion recovery and susceptibility-weighted imaging magnetic resonance imaging, post-traumatic brain atrophy and functional outcome (Glasgow outcome scale - extended).
MATERIALS AND METHODS: Twenty patients with a closed head injury and diffuse axonal injury detected with fluid-attenuated inversion recovery and susceptibility-weighted imaging were included. The total volumes of the diffuse axonal injury fluid-attenuated inversion recovery lesions were determined for each subject's initial (<14 days) and follow-up magnetic resonance scan (average: day 303 ± 83 standard deviation). The different brain volumes were automatically quantified using a validated and both US Food and Drug Administration-cleared and CE-marked machine learning algorithm (icobrain). The number of susceptibility-weighted imaging lesions and functional outcome scores (Glasgow outcome scale - extended) were retrieved from the Collaborative European NeuroTrauma Effectiveness Research Traumatic Brain Injury dataset.
RESULTS: The volumetric fluid-attenuated inversion recovery diffuse axonal injury lesion load showed a significant inverse correlation with functional outcome (Glasgow outcome scale - extended) (r = -0.57; P = 0.0094) and white matter volume change (r = -0.50; P = 0.027). In addition, white matter volume change correlated significantly with the Glasgow outcome scale - extended score (P = 0.0072; r = 0.58). Moreover, there was a strong inverse correlation between longitudinal fluid-attenuated inversion recovery lesion volume change and whole brain volume change (r = -0.63; P = 0.0028). No significant correlation existed between the number of diffuse axonal injury susceptibility-weighted imaging lesions, brain atrophy and functional outcome.
CONCLUSIONS: Volumetric analysis of diffuse axonal injury on fluid-attenuated inversion recovery imaging and automated brain atrophy calculation are potentially useful tools in the clinical management and follow-up of traumatic brain injury patients with diffuse axonal injury.

Entities:  

Keywords:  FLAIR; SWI; Traumatic brain injury (TBI); brain atrophy; functional outcome; magnetic resonance imaging (MRI)

Mesh:

Year:  2021        PMID: 34643120      PMCID: PMC9437508          DOI: 10.1177/19714009211049714

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  40 in total

1.  A method for reducing misclassification in the extended Glasgow Outcome Score.

Authors:  Juan Lu; Anthony Marmarou; Kate Lapane; Elizabeth Turf; Lindsay Wilson
Journal:  J Neurotrauma       Date:  2010-05       Impact factor: 5.269

2.  Functional outcome scales in traumatic brain injury: a comparison of the Glasgow Outcome Scale (Extended) and the Functional Status Examination.

Authors:  Anne M Hudak; R Ruth Caesar; Alan B Frol; Kim Krueger; Caryn R Harper; Nancy R Temkin; Sureyya S Dikmen; Mary Carlile; Christopher Madden; Ramon Diaz-Arrastia
Journal:  J Neurotrauma       Date:  2005-11       Impact factor: 5.269

Review 3.  What is the Relationship of Traumatic Brain Injury to Dementia?

Authors:  Mario F Mendez
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  MR-based brain and cerebrospinal fluid measurement after traumatic brain injury: correlation with neuropsychological outcome.

Authors:  D D Blatter; E D Bigler; S D Gale; S C Johnson; C V Anderson; B M Burnett; D Ryser; S E Macnamara; B J Bailey
Journal:  AJNR Am J Neuroradiol       Date:  1997-01       Impact factor: 3.825

5.  One year psychosocial outcome in head injury.

Authors:  S S Dikmen; B L Ross; J E Machamer; N R Temkin
Journal:  J Int Neuropsychol Soc       Date:  1995-01       Impact factor: 2.892

6.  Correlation between MRI findings and long-term outcome in patients with severe brain trauma.

Authors:  A Pierallini; P Pantano; L M Fantozzi; M Bonamini; R Vichi; R Zylberman; F Pisarri; C Colonnese; L Bozzao
Journal:  Neuroradiology       Date:  2000-12       Impact factor: 2.804

7.  Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI): a prospective longitudinal observational study.

Authors:  Andrew I R Maas; David K Menon; Ewout W Steyerberg; Giuseppe Citerio; Fiona Lecky; Geoffrey T Manley; Sean Hill; Valerie Legrand; Annina Sorgner
Journal:  Neurosurgery       Date:  2015-01       Impact factor: 4.654

8.  Susceptibility weighted imaging and its relationship to outcome after pediatric traumatic brain injury.

Authors:  Miriam H Beauchamp; Richard Beare; Michael Ditchfield; Lee Coleman; Franz E Babl; Michael Kean; Louise Crossley; Cathy Catroppa; Keith O Yeates; Vicki Anderson
Journal:  Cortex       Date:  2012-09-03       Impact factor: 4.027

9.  Prediction of brain age suggests accelerated atrophy after traumatic brain injury.

Authors:  James H Cole; Robert Leech; David J Sharp
Journal:  Ann Neurol       Date:  2015-04       Impact factor: 10.422

10.  A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER).

Authors:  Ellis Niemantsverdriet; Annemie Ribbens; Christine Bastin; Florence Benoit; Bruno Bergmans; Jean-Christophe Bier; Roxanne Bladt; Lene Claes; Peter Paul De Deyn; Olivier Deryck; Bernard Hanseeuw; Adrian Ivanoiu; Jean-Claude Lemper; Eric Mormont; Gaëtane Picard; Eric Salmon; Kurt Segers; Anne Sieben; Dirk Smeets; Hanne Struyfs; Evert Thiery; Jos Tournoy; Eric Triau; Anne-Marie Vanbinst; Jan Versijpt; Maria Bjerke; Sebastiaan Engelborghs
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.